38 related articles for article (PubMed ID: 25124581)
1. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.
Chen M; Huang J; Zhu Z; Zhang J; Li K
BMC Cancer; 2013 Nov; 13():539. PubMed ID: 24206575
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of β-Catenin Expression in Osteosarcoma: A Meta-Analysis.
Xie X; Li Y; Zhu H; Kuang Z; Chen D; Fan T
Front Oncol; 2020; 10():402. PubMed ID: 32328456
[No Abstract] [Full Text] [Related]
3. Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis.
Jin J; Zhan P; Katoh M; Kobayashi SS; Phan K; Qian H; Li H; Wang X; Wang X; Song Y;
Transl Lung Cancer Res; 2017 Feb; 6(1):97-108. PubMed ID: 28331830
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.
Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
[TBL] [Abstract][Full Text] [Related]
5. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.
Liu L; Zhi Q; Shen M; Gong FR; Zhou BP; Lian L; Shen B; Chen K; Duan W; Wu MY; Tao M; Li W
Oncotarget; 2016 Jul; 7(30):47145-47162. PubMed ID: 27323403
[TBL] [Abstract][Full Text] [Related]
6. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.
Wang ZY; Jiang YZ; Xiao W; Xue XB; Zhang XW; Zhang L
BMC Cancer; 2021 Sep; 21(1):988. PubMed ID: 34479538
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of osteopontin expression in esophageal squamous cell carcinoma: A meta-analysis.
Wang Y; Lu Y; Xu W; Wang Y; Wu Y; Che G
Pathol Res Pract; 2019 Oct; 215(10):152571. PubMed ID: 31387806
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of beta-catenin expression in patients with esophageal carcinoma: a meta-analysis.
Zeng R; Duan L; Kong YK; Wu XL; Wang Y; Xin G; Yang KH
Asian Pac J Cancer Prev; 2014; 15(15):6103-8. PubMed ID: 25124581
[TBL] [Abstract][Full Text] [Related]
11. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
